94 related articles for article (PubMed ID: 20471237)
1. Energy expenditure and impact of bronchodilators in COPD patients.
Cazzola M; Segreti A; Stirpe E; Appodia M; Senis L; Matera MG
Respir Med; 2010 Oct; 104(10):1490-4. PubMed ID: 20471237
[TBL] [Abstract][Full Text] [Related]
2. Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD.
Cazzola M; Biscione GL; Pasqua F; Crigna G; Appodia M; Cardaci V; Ferri L
Respir Med; 2008 Oct; 102(10):1425-30. PubMed ID: 18621519
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
4. Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD.
Richter K; Stenglein S; Mücke M; Sieder C; Schmidtmann S; Harnest U; Weidinger G; Magnussen H
Respiration; 2006; 73(4):414-9. PubMed ID: 16534180
[TBL] [Abstract][Full Text] [Related]
5. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation.
Santus P; Centanni S; Verga M; Di Marco F; Matera MG; Cazzola M
Respir Med; 2006 Jul; 100(7):1277-81. PubMed ID: 16337781
[TBL] [Abstract][Full Text] [Related]
7. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study.
Di Marco F; Verga M; Santus P; Morelli N; Cazzola M; Centanni S
Respir Med; 2006 Nov; 100(11):1925-32. PubMed ID: 16626956
[TBL] [Abstract][Full Text] [Related]
8. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
[TBL] [Abstract][Full Text] [Related]
9. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
Szmidt M
Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
[TBL] [Abstract][Full Text] [Related]
10. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.
Tashkin DP; Pearle J; Iezzoni D; Varghese ST
COPD; 2009 Feb; 6(1):17-25. PubMed ID: 19229704
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ
Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868
[TBL] [Abstract][Full Text] [Related]
12. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD.
Meyer T; Reitmeir P; Brand P; Herpich C; Sommerer K; Schulze A; Scheuch G; Newman S
Respir Med; 2011 Jun; 105(6):900-6. PubMed ID: 21397483
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with tiotropium and formoterol in chronic obstructive pulmonary disease: effect on the 6-minute walk test.
Jayaram L; Wong C; McAuley S; Rea H; Zeng I; O'Dochartaigh C
COPD; 2013 Aug; 10(4):466-72. PubMed ID: 23875741
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
Cazzola M; Gabriella Matera M
Respir Med; 2007 May; 101(5):957-62. PubMed ID: 17056241
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: a meta-analysis.
Wang J; Jin D; Zuo P; Wang T; Xu Y; Xiong W
Respirology; 2011 Feb; 16(2):350-8. PubMed ID: 21138499
[TBL] [Abstract][Full Text] [Related]
16. Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study.
Dal Negro RW; Turati C; Micheletto C; Menegoni F
Ther Adv Respir Dis; 2012 Apr; 6(2):97-105. PubMed ID: 22250038
[TBL] [Abstract][Full Text] [Related]
17. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
18. Short term effect of a single dose of formoterol or tiotropium on the isolated nocturnal hypoxemia in stable COPD patients: a double blind randomized study.
Sposato B; Franco C
Eur Rev Med Pharmacol Sci; 2008; 12(3):203-11. PubMed ID: 18700693
[TBL] [Abstract][Full Text] [Related]
19. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
20. Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function.
Cazzola M; Tashkin DP
COPD; 2009 Oct; 6(5):404-15. PubMed ID: 19863370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
